Vesugen is a tripeptide bioregulator (Lys-Glu-Asp) developed as part of the Khavinson peptide bioregulator series, with research focused on the vascular system and endothelial tissue. Originally developed at the St. Petersburg Institute of Bioregulation and Gerontology, Vesugen has been studied for its potential to support the structural and functional integrity of blood vessel walls, including effects on endothelial cell activity, smooth muscle regulation, and microvascular health.
In preclinical and observational research, Vesugen has been investigated for its influence on vascular tone, capillary permeability, and the regulation of angiogenic processes. Its short-chain peptide structure allows interaction with cell regulatory mechanisms, potentially modulating gene expression related to vascular maintenance and repair.
Each batch of Vesugen supplied by Peptician is independently verified to exceed 98% purity via HPLC analysis, ensuring consistency and reliability for scientific investigation. The product is supplied in lyophilised powder form, providing excellent stability during storage. Recommended storage conditions are at -20°C, protected from moisture and light, to maintain optimal integrity.
Molecular Formula
C₁₆H₂₇N₄O₈⁺
Molecular Weight
404.4 g/mol
Purity
>98%
CAS Number
1228573-04-3
Form
Lyophilised Powder
Research Applications
Vascular biology, Endothelial function research, Angiogenesis studies, Microcirculation research, Cardiovascular ageing, Peptide bioregulator research
For research purposes only. Not for human use. This product is intended solely for in vitro and preclinical research applications by qualified professionals.
Reviews
There are no reviews yet.